Logo image of GBT.PA

GUERBET (GBT.PA) Stock Overview

EPA:GBT - FR0000032526 - Common Stock

19.34 EUR
+0.14 (+0.73%)
Last: 9/5/2025, 7:00:00 PM

GBT.PA Key Statistics, Chart & Performance

Key Statistics
52 Week High39.35
52 Week Low17.42
Market Cap244.46M
Shares12.64M
Float5.25M
Yearly Dividend0.5
Dividend Yield2.69%
EPS(TTM)1.27
PE15.23
Fwd PE10.14
Earnings (Next)09-24 2025-09-24
IPO01-15 1986-01-15
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies


GBT.PA short term performance overview.The bars show the price performance of GBT.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15 -20 -25

GBT.PA long term performance overview.The bars show the price performance of GBT.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -20 -40

The current stock price of GBT.PA is 19.34 EUR. In the past month the price decreased by -7.46%. In the past year, price decreased by -41.13%.

GUERBET / GBT Daily stock chart

GBT.PA Competitors/Peers

The largest stocks on the EU markets in the "Health Care Supplies" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
EL.PA ESSILORLUXOTTICA 37.79 118.77B
1EL.MI ESSILORLUXOTTICA 37.45 117.72B
ESL.DE ESSILORLUXOTTICA 37.44 117.67B
2U3.DE ALCON INC 26.36 33.99B
CBHD.DE COLOPLAST-B 33.07 17.73B
GENT.OL GENTIAN DIAGNOSTICS ASA 20.82 863.52M
ALCJ.PA CROSSJECT N/A 71.59M
AFME.PA AFFLUENT MEDICAL SA N/A 57.06M
PTP.DE PENTIXAPHARM HOLDING AG N/A 41.66M

About GBT.PA

Company Profile

GBT logo image Guerbet SA engages in the research, development, manufacture, and sale of contrast products for medical imaging. The company is headquartered in Villepinte, Ile-De-France and currently employs 2,905 full-time employees. The company produces medical imaging contrast products for x-ray imaging, magnetic resonance imaging (MRI), ultrasound imaging and for nuclear medicine. The contrast agents are used in the diagnosis of cardio-vascular, inflammatory and neuro-degenerative disorders. The Company’s portfolio of products comprises brands, such as Xenetix, Hexabrix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol, among others. Guerbet SA is also active in the fine chemicals industry through its Simafex subsidiary. The firm operates through its subsidiaries, including Simafex, Medex, SCI KALB, Guerbet LLC, Guerbet Asie Pacifique and Guerbet GmbH, among others.

Company Info

GUERBET

15 rue des Vanesses, Zone Paris Nord II

Villepinte ILE-DE-FRANCE FR

Employees: 2842

GBT Company Website

GBT Investor Relations

Phone: 33145915000

GUERBET / GBT.PA FAQ

What is the stock price of GUERBET today?

The current stock price of GBT.PA is 19.34 EUR. The price increased by 0.73% in the last trading session.


What is the ticker symbol for GUERBET stock?

The exchange symbol of GUERBET is GBT and it is listed on the Euronext Paris - Matif exchange.


On which exchange is GBT.PA stock listed?

GBT.PA stock is listed on the Euronext Paris - Matif exchange.


What is the price forecast or stock price prediction for GUERBET stock?

8 analysts have analysed GBT.PA and the average price target is 26.78 EUR. This implies a price increase of 38.44% is expected in the next year compared to the current price of 19.34. Check the GUERBET stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is GUERBET worth?

GUERBET (GBT.PA) has a market capitalization of 244.46M EUR. This makes GBT.PA a Micro Cap stock.


How many employees does GUERBET have?

GUERBET (GBT.PA) currently has 2842 employees.


What are the support and resistance levels for GUERBET (GBT.PA) stock?

GUERBET (GBT.PA) has a resistance level at 22.29. Check the full technical report for a detailed analysis of GBT.PA support and resistance levels.


Is GUERBET (GBT.PA) expected to grow?

The Revenue of GUERBET (GBT.PA) is expected to grow by 2.48% in the next year. Check the estimates tab for more information on the GBT.PA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy GUERBET (GBT.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does GUERBET (GBT.PA) stock pay dividends?

GUERBET (GBT.PA) has a dividend yield of 2.69%. The yearly dividend amount is currently 0.5. Check the full fundamental report for a detailed analysis of GBT.PA dividend history, reliability and sustainability.


When does GUERBET (GBT.PA) report earnings?

GUERBET (GBT.PA) will report earnings on 2025-09-24.


What is the Price/Earnings (PE) ratio of GUERBET (GBT.PA)?

The PE ratio for GUERBET (GBT.PA) is 15.23. This is based on the reported non-GAAP earnings per share of 1.27 and the current share price of 19.34 EUR. Check the full fundamental report for a full analysis of the valuation metrics for GBT.PA.


GBT.PA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

GBT.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to GBT.PA. GBT.PA has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

GBT.PA Financial Highlights

Over the last trailing twelve months GBT.PA reported a non-GAAP Earnings per Share(EPS) of 1.27. The EPS decreased by -34.2% compared to the year before.


Industry RankSector Rank
PM (TTM) 1.91%
ROA 1.55%
ROE 4.08%
Debt/Equity 0.89
Chartmill High Growth Momentum
EPS Q2Q%-77.4%
Sales Q2Q%3.65%
EPS 1Y (TTM)-34.2%
Revenue 1Y (TTM)7.05%

GBT.PA Forecast & Estimates

8 analysts have analysed GBT.PA and the average price target is 26.78 EUR. This implies a price increase of 38.44% is expected in the next year compared to the current price of 19.34.

For the next year, analysts expect an EPS growth of -25.91% and a revenue growth 2.48% for GBT.PA


Analysts
Analysts75
Price Target26.78 (38.47%)
EPS Next Y-25.91%
Revenue Next Year2.48%

GBT.PA Ownership

Ownership
Inst Owners18.21%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A